Difference between revisions of "File:Fig2 White PractLabMed2021 26.jpg"
Shawndouglas (talk | contribs) |
Shawndouglas (talk | contribs) (Added summary.) |
||
| Line 1: | Line 1: | ||
==Summary== | |||
{{Information | |||
|Description='''Figure 2.''' Laboratory Stewardship Data Dashboard for Thyroid Screening Orders, First Quarter 2019. The upper left box shows exceptions to the health system's test ordering guidelines for commonly selected tests. The upper right box shows clinician-specific impact of the thyroid testing intervention when the system promulgated the rules (showing only the providers with the highest number of exceptions). The bottom chart shows migration from the inappropriate screening and adoption of the appropriately-indicated TSH test for initial screening. CT, Chlamydia trachomatis; Endo, endocrinology; HEP C, hepatitis C; HIV, human immunodeficiency virus; hrHPV, high-risk human papillomavirus; NG, Neisseria gonorrhoeae; Ob-Gyn, obstetrics and gynecology; T3, triiodothyronine; T4, thyroxine; TSH, thyroid-stimulating hormone; VIT D, vitamin D. | |||
|Source={{cite journal |title=Strategies for laboratory professionals to drive laboratory stewardship |journal=Practical Laboratory Medicine |author=White, T.E.; Wong, W.B.; Janowiak, D.; Hilborne, L.H. |volume=26 |at=e00249 |year=2021 |doi=10.1016/j.plabm.2021.e00249}} | |||
|Author=White, T.E.; Wong, W.B.; Janowiak, D.; Hilborne, L.H. | |||
|Date=2021 | |||
|Permission=[http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International] | |||
}} | |||
== Licensing == | == Licensing == | ||
{{cc-by-4.0}} | {{cc-by-4.0}} | ||
Latest revision as of 17:01, 10 August 2021
Summary
| Description |
Figure 2. Laboratory Stewardship Data Dashboard for Thyroid Screening Orders, First Quarter 2019. The upper left box shows exceptions to the health system's test ordering guidelines for commonly selected tests. The upper right box shows clinician-specific impact of the thyroid testing intervention when the system promulgated the rules (showing only the providers with the highest number of exceptions). The bottom chart shows migration from the inappropriate screening and adoption of the appropriately-indicated TSH test for initial screening. CT, Chlamydia trachomatis; Endo, endocrinology; HEP C, hepatitis C; HIV, human immunodeficiency virus; hrHPV, high-risk human papillomavirus; NG, Neisseria gonorrhoeae; Ob-Gyn, obstetrics and gynecology; T3, triiodothyronine; T4, thyroxine; TSH, thyroid-stimulating hormone; VIT D, vitamin D. |
|---|---|
| Source |
White, T.E.; Wong, W.B.; Janowiak, D.; Hilborne, L.H. (2021). "Strategies for laboratory professionals to drive laboratory stewardship". Practical Laboratory Medicine 26: e00249. doi:10.1016/j.plabm.2021.e00249. |
| Date |
2021 |
| Author |
White, T.E.; Wong, W.B.; Janowiak, D.; Hilborne, L.H. |
| Permission (Reusing this file) |
|
| Other versions |
Licensing
  |
This work is licensed under the Creative Commons Attribution 4.0 License. |
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 16:59, 10 August 2021 |  | 624 × 386 (147 KB) | Shawndouglas (talk | contribs) |
You cannot overwrite this file.
File usage
The following page uses this file:
